Clinical Trial Update: A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating automated CO2 injection during peripheral vascular interventions to spare iodinated contrast and prevent major adverse kidney …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Peripheral Vascular Disease

Snippet

Sponsor: University of Leipzig | Conditions: Peripheral Vascular Diseases, Kidney Diseases | Phase 3 | Status: RECRUITING